{"database": "openregs", "table": "documents", "rows": [["FDA-2010-P-0630-0006", "FDA", "FDA-2010-P-0630", "Attachment VI - \"Development of biokinetic models for the description of the effect of DTPA with regard to the diagnostic and therapy of incorporation of plutonium and other transuranium elements\" - Heyltex Corporation - [HEYL Chemisch-pharmazeutische Fabrik GmbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:29:18Z", null, 0, 0, "0900006480bb3df7"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2010-P-0630-0006"], "units": {}, "query_ms": 87.69207098521292, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}